The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J06 | Immune sera and immunoglobulins | |
| 3 | J06B | Immunoglobulins | |
| 4 | J06BB | Specific immunoglobulins | |
| 5 | J06BB09 | Cytomegalovirus immunoglobulin |
| Active Ingredient | Description | |
|---|---|---|
| Cytomegalovirus immunoglobulin |
Cytomegalovirus immunoglobulin is used as a CMV-specific polyclonal immunoglobulin preparation that binds to CMV surface antigens thereby neutralizing the potential of CMV from entering host cells and presenting the CMV particle for phagocytosis. Furthermore, cytomegalovirus immunoglobulin can activate CMV-reactive immune cells for long-lasting CMV-specific immune responses. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CYTOGAM Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| CYTOTECT CP BIOTEST Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
